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orphogenesis of the 
 
Drosophila
 
 
 
melanogaster
 
embryo is associated with a dynamic reorgani-
zation of the actin cytoskeleton that is mediated
by small GTPases of the Rho family. Often, 
 
Rho1
 
 controls
different aspects of cytoskeletal function in parallel, requiring
a complex level of regulation. We show that the guanine
triphosphate (GTP) exchange factor DRhoGEF2 is apically
localized in epithelial cells throughout embryogenesis. We
demonstrate that 
 
DRhoGEF2
 
, which has previously been
shown to regulate cell shape changes during gastrulation,
M
 
recruits Rho1 to actin rings and regulates actin distribution
and actomyosin contractility during nuclear divisions, pole
cell formation, and cellularization of syncytial blastoderm
embryos. We propose that 
 
DRhoGEF2
 
 activity coordinates
contractile actomyosin forces throughout morphogenesis in
 
Drosophila
 
 by regulating the association of myosin with
actin to form contractile cables. Our results support the
hypothesis that speciﬁc aspects of 
 
Rho1
 
 function are regu-
lated by speciﬁc GTP exchange factors.
 
Introduction
 
Animal development is associated with extensive morphological
changes of individual cells and entire tissues. Often, these
changes require a dynamic rearrangement of the cortical acto-
myosin-based cytoskeleton. One example is the early phase of
embryogenesis in 
 
Drosophila melanogaster
 
. Development of
the 
 
Drosophila
 
 zygote begins with 13 synchronous nuclear
division cycles that create a syncytial embryo containing 
 
 
 
6,000
nuclei. During mitotic cycles, 10–13 shallow metaphase fur-
rows form transiently between neighboring nuclei at the cell
cortex, thus preventing mitotic spindles from colliding. Formation
of the furrows is accompanied by relocalization of actin from
apical caps into actin rings located at the base of the furrows.
Blastoderm cellularization occurs during interphase of cycle 14
when simultaneous cytokinesis transforms the monolayer of
syncytial nuclei into a columnar epithelium. This process can
be subdivided into a slow and a fast phase, and both phases
require distinct cytoskeletal rearrangements. During the early
slow phase, cell membranes begin to invaginate radially between
the nuclei and form stable infoldings called the furrow canal.
The leading edge of the furrow canal is rich in actin and myo-
sin, which form a hexagonal array surrounding the nuclei. As
the actomyosin network moves inward, the nuclei, which are
spherical at the onset of cellularization, begin to elongate.
When the cellularization front has reached the base of the nu-
clei, the rate of membrane invagination increases by twofold.
During this fast phase, actomyosin rings in the furrow canal
constrict to close the blastoderm cells basally (for review see
Mazumdar and Mazumdar, 2002).
Although some of the genes involved in cytoskeletal re-
arrangement during cellularization, such as the small GTPase
 
Rho1
 
 (Crawford et al., 1998), the cytoskeletal regulator 
 
diaph-
anous
 
 (
 
dia
 
; Afshar et al., 2000) and the zygotic genes 
 
nullo
 
,
 
serendipity-
 
 
 
, and 
 
bottleneck
 
 (
 
bnk
 
; Schejter and Wieschaus,
1993; Postner and Wieschaus, 1994) have been identified, the
genetic circuitry regulating the actomyosin contractile apparatus
is not well understood.
The small GTPase 
 
Rho1
 
 has been identified as a powerful
regulator of cytoskeletal reorganization in many contexts. In
 
Drosophila
 
, 
 
Rho1
 
 has been demonstrated to play an essen-
tial role during oogenesis (Magie et al., 1999), cellularization
(Crawford et al., 1998), gastrulation (Barrett et al., 1997;
Häcker and Perrimon, 1998), segmentation, dorsal closure
(Magie et al., 1999), planar polarity determination (Strutt et al.,
1997) and cytokinesis (Prokopenko et al., 1999). In many of
these processes, 
 
Rho1
 
 controls the spatial and temporal coordi-
nation of different aspects of cytoskeletal function such as actin
polymerization or contraction of actomyosin fibers in parallel,
implying a complex level of regulation of 
 
Rho1
 
 activity. Like
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other members of the small GTPase family, 
 
Rho1
 
 acts as a mo-
lecular switch that is inactive when GDP is bound and acti-
vated upon exchange of GDP for GTP by GTP exchange fac-
tors (for review see Settleman, 2001).
During cytokinesis, which is mechanistically related
to blastoderm cellularization, a linear pathway that includes
Dia—the formin homology protein—and profilin—an actin-
binding protein that regulates actin polymerization—has been
proposed to link Rho1 to the actin cytoskeleton. The RhoGEF
 
pebble
 
 has been shown to activate Rho1 in this context. Pebble
is localized to contractile actin rings during cytokinesis in a cell
cycle–regulated fashion. The function of 
 
pebble
 
 is considered
essential for the assembly of actin rings during cytokinesis in
all cells during 
 
Drosophila
 
 embryogenesis subsequent to cell
cycle 14 (Prokopenko et al., 1999). Recently, 
 
pebble
 
 has also
been shown to regulate the lateral migration of mesodermal
cells (Schumacher et al., 2004; Smallhorn et al., 2004). Inter-
estingly, 
 
pebble
 
 is not required during syncytial nuclear divi-
sions or during blastoderm cellularization, suggesting that a
different RhoGEF may activate Rho1 during this phase of de-
velopment (Lehner, 1992).
A likely candidate is 
 
DRhoGEF2
 
, which is maternally
contributed to the embryo and ubiquitously expressed through-
out embryogenesis. 
 
DRhoGEF2
 
 has previously been shown to
regulate the apical constriction of cells during invagination of
the mesodermal and endodermal germ layers immediately after
cellularization (Barrett et al., 1997; Häcker and Perrimon,
1998). We have used 
 
 
 
-DRhoGEF2 antiserum to investigate
the role of 
 
DRhoGEF2
 
 during early embryogenesis in more de-
tail. Here, we show that DRhoGEF2 colocalizes with actin,
myosin II, Rho1, Dia, and Bnk in the furrow canal during cellu-
larization and is required for the recruitment of Rho1 to the cel-
lularization front. 
 
DRhoGEF2
 
 regulates actin localization and
actin ring constriction during pole cell formation, metaphase
furrow formation, and cellularization. Based on our results, we
propose that 
 
DRhoGEF2
 
 regulates a specific aspect of Rho1-
mediated cytoskeletal reorganization throughout 
 
Drosophila
 
morphogenesis.
 
Results
 
DRhoGEF2 is apically enriched in 
epithelia throughout embryogenesis
 
DRhoGEF2
 
 transcripts are maternally contributed to the em-
bryo and ubiquitously expressed throughout embryogenesis.
However, we observed 
 
DRhoGEF2
 
-dependent cytoskeletal re-
organization in a tissue-specific fashion during development
and suggest that 
 
DRhoGEF2
 
 activity may be regulated at the
protein level. To investigate the subcellular localization of
DRhoGEF2, we stained wild-type embryos with 
 
 
 
-DRhoGEF2
antibodies (Rogers et al., 2004). DRhoGEF2 was detected pre-
dominantly in epithelia throughout embryogenesis and was en-
riched at the apical end of cells. In agreement with its previ-
ously reported role during gastrulation, DRhoGEF2 levels were
elevated at the apical and apico-lateral membrane of cells in the
ventral furrow (Fig. 1 A), in the posterior midgut primordium
(Fig. 1 B), and in the cephalic furrow (Fig. 1 C). After germ
band elongation, DRhoGEF2 was detectable at the apical end
of cells in the epidermis (Fig. 1 D). After germ band retraction,
DRhoGEF2 levels were elevated in a periodically repeated pat-
tern in the ventral epidermal cells of thoracic and abdominal
segments (Fig. 1 E). In the central nervous system, DRhoGEF2
was concentrated in longitudinal and commissural axon fasci-
cles (Fig. 1, E and F). In the lateral epidermis, DRhoGEF2
was highly concentrated at the apical cortex of leading edge
cells during dorsal closure (Fig. 1 G). These data suggest that
 
DRhoGEF2
 
 may play a role in reorganizing the cortical actin
cytoskeleton throughout embryonic development.
 
DRhoGEF2 is localized in actin- and 
myosin-rich regions during cellularization
 
During the interphase of syncytial nuclear cycles,
DRhoGEF2 was found concentrated in the apical actin caps
(Fig. 2 A). At prophase, DRhoGEF2 relocalized to the
metaphase furrows (Fig. 2 B), where its levels were highest
at the center of the broader actin domain (Fig. 2 B, arrow).
At the onset of cellularization, the majority of DRhoGEF2
Figure 1. Expression of DRhoGEF2 during embryonic development.
(A–C) DRhoGEF2 protein accumulates apically in cells of the invaginating
ventral furrow (A and C, arrows), in cells of the posterior midgut primordium
(B, arrow), and in cells in the cephalic fold (C, arrowhead). (D) At late
stage 11, DRhoGEF2 is apically localized in all epidermal cells. (E) At late
stage 14, DRhoGEF2 is enriched in a periodic pattern in the epidermis
(arrows) and in commissural axon tracts (arrowhead). (F) DRhoGEF2 is
enriched in longitudinal and commissural axon tracts in the central nervous
system. (G) During dorsal closure of the epidermis, DRhoGEF2 is highly
enriched at the apical cortex of leading edge cells. Anterior is to the left.
B–E show lateral views; A and F show ventral views; and G shows dorsal
view. Bars: (A–C) 10  m; (D–G) 50  m. 
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redistributed to the base of the furrow canal (Fig. 2 C). Api-
cal levels were low at this time, but increased again gradu-
ally during the slow phase (Fig. 2 D), suggesting that
DRhoGEF2 might play a role in the retraction of apical mi-
crovilli that occurs during cellularization (Grevengoed et al.,
2003). Double labeling experiments showed that DRhoGEF2
colocalized with actin and myosin II at the base of the furrow
canal (Fig. 2 and Fig. S1, available at http://www.jcb.org/
cgi/content/full/jcb.200407124/DC1]). Moderate levels of
DRhoGEF2 also remained associated with lateral mem-
branes (Fig. 2, D and E). During basal closure of blastoderm
cells, DRhoGEF2 was detectable in a thin stripe at the basal-
most boundary of the actin and myosin II domains (Fig. 2 E
and Fig. S1 C). The localization of DRhoGEF2 at sites of ac-
tin rings suggests that it might play a role in the regulation of
actomyosin-based forces during cellularization.
It is noteworthy that DRhoGEF2 was also seen in large
particles that are most abundant during the early phase of mem-
brane invagination (Fig. 2, A–C). Similar particles that are
transported to the cellularization front in a microtubule-depen-
dent fashion have been reported for myosin II (Royou et al.,
2004). Although we were unable to detect myosin II particles,
it is possible that the DRhoGEF2 particles might have a similar
function in transport of DRhoGEF2 to the apical cortex.
 
DRhoGEF2
 
 regulates actomyosin 
contractility during early embryogenesis
 
It has previously been shown that 
 
DRhoGEF2
 
 is required for
apical constriction of cells in the mesodermal and endodermal
primordia during gastrulation (Barrett et al., 1997; Häcker and
Perrimon, 1998). 
 
DRhoGEF2
 
 protein distribution suggests that
 
DRhoGEF2
 
 may also have an earlier function. To investigate
the role of 
 
DRhoGEF2
 
 during the syncytial phase of embryo-
genesis and cellularization, we generated germline clones from
a 
 
DRhoGEF2
 
 null allele (embryos derived from 
 
DRhoGEF2
 
mutant germline clones are hereafter referred to as 
 
DRhoGEF2
 
mutants; see Materials and methods).
In wild-type embryos, actin cycles between apical actin
caps and metaphase furrows during nuclear divisions 10–13 (Fig.
3, A and A
 
 
 
). At the onset of cellularization, actin relocalizes from
the actin caps to the furrow canal where it forms a network of in-
terlinked actin hexagons that surround the nuclei (Fig. 3, C and
C
 
 
 
). In the course of the slow phase of membrane invagination,
apical actin is almost completely redistributed to the base of the
furrow canal (Fig. 3 E). When the cellularization front reaches the
base of the nuclei, the actin hexagons detach from each other and
begin to contract, thereby expanding the furrow canal (Fig. 3 E
 
 
 
).
Contraction of actin rings eventually leads to basal closure of the
newly formed blastoderm cells (Fig. 3, G and G
 
 
 
).
Figure 2. Distribution of DRhoGEF2 during blastoderm
cellularization. DRhoGEF2 is shown in green; actin is shown
in red, and DNA is shown in blue. (A) At the interphase of
syncytial divisions DRhoGEF2 is concentrated in apical actin
caps. (B) During syncytial nuclear cycles DRhoGEF2 redistributes
to the metaphase furrows. The DRhoGEF2 domain is narrower
than the actin domain (arrow). DRhoGEF2 is also observed in
large cytoplasmic vesicles. (C) At the onset of cellularization,
DRhoGEF2 redistributes to the furrow canal (arrow). Apical
DRhoGEF2 levels are low. (D) DRhoGEF2 remains concen-
trated at the base of the furrow canal throughout membrane
invagination. Apical DRhoGEF2 levels increase during the
slow phase. (E) During basal closure, DRhoGEF2 is enriched
at the basal-most edge of blastoderm cells in the region
where actin rings are located (arrowheads). Left three panels
show sagittal views; right panels show grazing view. Bars,
10  m. 
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In 
 
DRhoGEF2
 
 mutants, the depth of metaphase furrows
is more variable than in the wild type, and actin is more un-
evenly distributed (Fig. 3, B and B
 
 
 
). In some areas, metaphase
furrows fail to invaginate or break down; this failure can cause
adjacent mitotic spindles to collide (Fig. 3 B
 
 
 
, arrow) and leads
to the elimination of nuclei from the cortex, which results in
empty “pseudocells” (Fig. 3 B
 
  
 
and Video 1 [available at http://
www.jcb.org/cgi/content/full/jcb.200407124/DC1]; Greven-
goed et al., 2003).
At the onset of cellularization, less actin is localized to
the furrow canal and apical actin levels remain higher in
 
DRhoGEF2
 
 mutants (Fig. 3 D). Actin rings appear rounded in-
stead of hexagonal, as if they are not under tension. In the wild
type, actin hexagons tightly surround the nuclei and slightly
squeeze them. In contrast, nuclei in 
 
DRhoGEF2
 
 mutants are
wider and abnormal, and multinucleated actin rings are fre-
quently observed (Fig. 3 D
 
 
 
). Because abnormal nuclei are re-
moved from the cell surface, we believe that they arise during
cellularization rather than being the results of earlier defects
during nuclear divisions. When the cellularization front reaches
the base of the nuclei, actin rings stay in proximity to each
other, and no significant constriction is observed (Fig. 3, F and
F
 
 
 
). During the subsequent fast phase, constriction is irregular,
and many multinucleated actin rings remain very large (Fig. 3,
H and H
 
 
 
). Significant amounts of actin fail to localize to the
cellularization front and remain apical (Fig. 3, F and H). We
conclude from these results that 
 
DRhoGEF2
 
 activity is re-
quired for the organization and stabilization of actin rings at in-
vaginating furrows and for the regulation of contractile acto-
myosin forces during cellularization.
The generation of contractile force requires actin to asso-
ciate with myosin II, which is encoded by the 
 
spaghetti squash
 
(
 
sqh
 
) gene. To assess whether the defects in actomyosin con-
traction may be caused by mislocalization of myosin II, we ex-
pressed an 
 
sqh
 
-GFP fusion protein (Royou et al., 2004) in
 
DRhoGEF2
 
 mutants, but no significant changes in localization
or levels of myosin II were observed (Fig. S2, available at http:
//www.jcb.org/cgi/content/full/jcb.200407124/DC1). Next, we
followed the time course of cellularization by time-lapse con-
focal microscopy (Video 2). Interestingly, a decrease in the rate
of membrane invagination was not observed in 
 
DRhoGEF2
 
mutants. Often, it seemed that the rate was slightly increased
instead; this observation suggests that actomyosin contractility
might not play a role or play only a very minor role in mem-
brane invagination. In addition, these experiments revealed that
the radial movement of nuclei was irregular in 
 
DRhoGEF2
 
 mu-
tants. In the wild type, nuclei move inward in parallel to each
other during the slow phase. In 
 
DRhoGEF2
 
 mutants, coordina-
tion of this movement is disrupted and some nuclei remain api-
cal, suggesting that actomyosin-based forces may play a role in
nuclear alignment.
 
DRhoGEF2 is required for Rho1 
localization
 
DRhoGEF2
 
 has previously been implicated in the regulation
of 
 
Rho1
 
 activity (Barrett et al., 1997; Häcker and Perri-
mon, 1998). To investigate whether 
 
Rho1
 
 may be a target for
 
DRhoGEF2
 
 during cellularization, we determined the localiza-
tion of Rho1 with respect to DRhoGEF2 and found that Rho1
colocalizes precisely with DRhoGEF2 at the base of the furrow
canal (Fig. 4, A–C). To define the domain of DRhoGEF2
and Rho1 localization more precisely, we double-labeled em-
bryos with 
 
 
 
-Heavy spectrin and Rho1. It has been shown that
 
 
 
-Heavy spectrin is present in the furrow canal in a domain
apically adjacent to myosin II (Thomas and Kiehart, 1994). We
found that Rho1 and, by inference, DRhoGEF2 are localized
basal to 
 
 
 
-Heavy spectrin at the basal-most boundary of the
myosin II domain (Fig. 4, D and E).
Figure 3. Phenotype of DRhoGEF2 mutants during blasto-
derm cellularization. Actin is shown in red; and DNA is
shown in blue. (A and A ) Metaphase furrows at cycle 13
in the wild type are shown. (B and B ) Same stage in
DRhoGEF2
l(2)04291 is shown. Metaphase furrows invagi-
nate to variable depths (B, arrow) and actin is irregularly
distributed. Sometimes furrow formation fails (B , arrow).
Abnormal nuclei are eliminated from the cell surface
(B , arrowhead; and Video 1). (C and C ) Slow phase in
the wild type is shown. (D and D ) Same stage in
DRhoGEF2
l(2)04291 is shown. Significant amounts of actin
fail to redistribute to the furrow canal, but remain apical
(D, F, and H, arrows). Nuclei are not squeezed by the
furrow and are wider than in the wild type. Actin rings have
a rounded rather than a hexagonal shape, are irregular
in size, and are frequently multinucleated (D ). (E and E )
Onset of the fast phase in the wild type is shown. (F and
F ) Same stage in DRhoGEF2
l(2)04291 is shown. The furrow
canal does not expand and no constriction of actin rings
is observed. (G and G ) Shown is the basal closure in the
wild type. (H and H ) Same stage in DRhoGEF2
l(2)04291.
Actin rings are irregular in size and some remain very
large. A–H show sagittal views at the same magnification;
A –H  show grazing views at the same magnification.
Bars, 10  m.ROLE OF DRHOGEF2 IN ACTOMYOSIN • PADASH BARMCHI ET AL. 579
Rho1 is essential for cytoskeletal regulation during oogen-
esis in Drosophila, and female germline clones mutant for Rho1
null alleles do not survive (Magie et al., 1999), precluding a ge-
netic analysis of Rho1 function in the embryo. To overcome this
problem, we have generated a piggyBac insertion in the 5 -
untranslated region of Rho1. Embryos, derived from germline
clones mutant for this allele, Rho1
L3, develop with variable de-
fects that range from failure to establish organized actin struc-
tures in the most severe cases (Fig. 5 A and Fig. S3 A [available
at http://www.jcb.org/cgi/content/full/jcb.200407124/DC1]) to
irregular and often only partial membrane invagination in the
least severe cases (Fig. 5 B and Fig. S3 B). Although low levels
of Rho1 must be present in these embryos, the Rho1 that local-
ized to the furrow canal was consistently below the detection
threshold of  -Rho1 antibodies (Fig. 5 B). If Rho1 were required
to recruit DRhoGEF2, one might expect that this reduction in
Rho1 levels would result in a reduction of DRhoGEF2 at the fur-
row canal. However, this was not observed (Fig. 5 B). Although
we cannot exclude that the reduced amount of Rho1 might be
able to recruit similar levels of DRhoGEF2 to the furrow canal as
in the wild type, we believe it is more likely that DRhoGEF2 is
localized independent of Rho1. Conversely, when DRhoGEF2
mutants were stained with  -Rho1 antibodies, localization of
Rho1 was disrupted (Fig. 5 C), suggesting that DRhoGEF2 may
recruit Rho1 to the furrow canal.
It has been proposed that the formin homology protein di-
aphanous (Dia) is a Rho1 effector during the assembly of actin
rings. Dia is required for the localization of several actin-bind-
ing proteins such as anillin (Field and Alberts, 1995) and pea-
nut (Pnut; Cooper and Kiehart, 1996) at the furrow canal (Af-
shar et al., 2000). To determine whether Dia may be involved
in DRhoGEF2 localization, we generated germline clones of
the null allele dia
5. Although maternally mutant dia
5 embryos
have severe cellularization defects, DRhoGEF2 concentration
at the furrow canal was unaffected (Fig. 5 D). Conversely, lo-
calization of Dia (Fig. 5 C) and the Drosophila septin family
protein Pnut (not depicted) was unaffected in DRhoGEF2 mu-
tants. We conclude that DRhoGEF2 may be localized to the
cellularization front independently of Dia and Rho1.
DRhoGEF2 acts in concert with bnk 
during cellularization
The actin-binding protein Bnk plays an important role during
cellularization (Schejter and Wieschaus, 1993). It has been pro-
Figure 4. Localization of DRhoGEF2 with respect to Rho1 and  -Heavy
spectrin. (A–C) DRhoGEF2 (green) and Rho1 (red) colocalize precisely at
the furrow canal during membrane invagination. (D and E)  -Heavy spectrin
(green) and Rho1 (red) are localized in adjacent nonoverlapping mem-
brane subdomains (compare arrowheads). (right) Merge of the left two
panels. All panels have the same magnification. Bar, 10  m.
Figure 5. Localization of DRhoGEF2 in Rho1
L3, dia
5 and, bnk mutants.
(A) Rho1
L3 embryo stained for actin (red) and DRhoGEF2 (green). Exam-
ple of severe phenotype. Although actin structures are severely disrupted,
DRhoGEF2 is concentrated at actin-rich structures (compare arrows). (B)
Rho1
L3 embryo stained for Rho1 (red) and DRhoGEF2 (green). Example of
less severe phenotype (possibly caused by paternal rescue; Fig. S3).
DRhoGEF2 localization is unaffected although Rho1 is reduced to back-
ground levels (compare arrows). (C) DRhoGEF2
l(2)04291 embryo stained for
Rho1 (red) and Dia (green). Concentration of Rho1 at the furrow canal is
abrogated (compare arrows). Localization of Dia at the furrow canal is
not affected. (D) dia
5 embryo stained for actin (red) and DRhoGEF2
(green). DRhoGEF2 concentration at the furrow canal (arrow) is unaffected.
(E) Df(3R)tll-e embryo (bnk mutant) stained for actin (red) and DRhoGEF2
(green). Actin rings contract prematurely pinching the nuclei. DRhoGEF2
distribution is not affected by the absence of bnk function. DNA is stained
in blue. (right) Merge of left two panels. Bars, 10  m.JCB • VOLUME 168 • NUMBER 4 • 2005 580
posed that Bnk links the actomyosin hexagons surrounding in-
dividual nuclei and thereby creates a network that is kept under
tension by the contractile force of actomyosin fibers (Theur-
kauf, 1994). Bnk is tightly associated with the lateral edges of
adjacent actin hexagons, but is absent from the vertices (Fig. 6
A ). To investigate the functional relationship between bnk and
DRhoGEF2, we stained wild-type and DRhoGEF2 mutant em-
bryos for Bnk.
bnk is a zygotically expressed gene and bnk protein is
first detectable shortly after the onset of zygotic transcription
when it is present at the apical surface during interphase and at
metaphase furrows during syncytial divisions (Schejter and
Wieschaus, 1993). At the onset of cellularization, Bnk redis-
tributes to the base of the furrow canal (Fig. 6, A and A ),
where it is detectable throughout the slow phase of membrane
invagination (Fig. 6, C and C ). Bnk is rapidly degraded during
the fast phase.
In DRhoGEF2 mutants, a significant change in the over-
all levels of Bnk was not observed. However, levels of Bnk
concentrated at the base of the furrow canal were decreased, as
seen from the less intense staining and the more restricted dis-
tribution in the grazing confocal sections (Fig. 6, B and B ). At
the time when the furrow canal had reached the base of the nu-
clei, Bnk was still present in the wild type (Fig. 6, C and C ),
whereas no localized Bnk was detectable in DRhoGEF2 mu-
tants, (Fig. 6, D and D ). Conversely, DRhoGEF2 protein lev-
els or localization was unaffected in bnk mutants (Fig. 5 E).
The premature disappearance of Bnk in DRhoGEF2 mutants is
not caused by a decreased rate of membrane invagination (see
DRhoGEF2 regulates actomyosin…). 
This led us to speculate that DRhoGEF2 might play a role
in Bnk stabilization. To test this hypothesis, we generated the
DRhoGEF2 expression construct UAS-DRhoGEF2-RE. When
UAS-DRhoGEF2-RE was expressed ubiquitously using the
mat 4Gal-VP16 driver (Häcker and Perrimon, 1998) in
DRhoGEF2 mutants, the ventral open cuticle defect, was res-
cued (Fig. 7 B), suggesting that UAS-DRhoGEF2-RE can
provide DRhoGEF2 function. When we expressed UAS-
DRhoGEF2-RE using prd-Gal4, Bnk accumulated in a pair
rule pattern in the epidermis (Fig. 7 C). This accumulation was
not caused by DRhoGEF2-mediated transcriptional activation,
because no increase in bnk mRNAs was observed (unpublished
data). We conclude from these results that DRhoGEF2 and Bnk
may be recruited to actin-rich regions independent of each
other, and that DRhoGEF2 may play a role in the stabilization
of Bnk.
The development of bnk mutants during syncytial nuclear
divisions is indistinguishable from the wild type. However,
shortly after the onset of membrane invagination, actin hexa-
gons transform into rings, which constrict prematurely and
cause the “bottleneck” phenotype (Fig. 5 E; Schejter and Wie-
schaus, 1993). To determine whether the premature constric-
tion of actin rings requires DRhoGEF2 function, we generated
DRhoGEF2-bnk double mutants. During syncytial divisions,
Figure 6. Localization of Bnk in DRhoGEF2 mutants
and phenotype of DRhoGEF2-bnk double mutants.
(A–D) Bnk. Insets depict the same image with Bnk in
green and actin in red. (E–H) Actin is shown in red;
and DNA is shown in blue. (A –H ) Corresponding
grazing views of A–H. (A) Wild type at the slow phase
is shown. (B) Same stage as A in DRhoGEF2
l(2)04291 is
shown. Bnk concentration at the furrow canal is reduced
(compare arrows in A and B). (C) Wild type at the end
of the slow phase is shown. (D) Same stage as C in
DRhoGEF2
l(2)04291 is shown. Bnk is not detectable at
the furrow canal. (E–H) DRhoGEF2-bnk double mutants.
(E) Metaphase furrows invaginate nonuniformly and
occasionally fail to form (E , arrow). Nuclei drop out of
the cortical layer (E, arrowhead) and leave behind
empty pseudocells (E , arrowhead). (F) Early slow
phase. Between some nuclei the furrow canal fails to
invaginate (F, arrow) leading to multinucleated actin
rings (F ). (G) Late slow phase. The actin network pro-
gressively disintegrates. Remaining actin rings do not
constrict as in bnk mutants (arrow). (H) At later stages
(as judged by the increased depth at which actin is
found), actin forms randomly distributed aggregates.
A–H show sagittal views at same magnification;
A –H  show grazing views at same magnification.
Bars, 10  m.
Figure 7. Rescue of DRhoGEF2 mutants and ectopic DRhoGEF2 expres-
sion. (A) DRhoGEF2
l(2)04291 cuticle showing ventral hole. (B) Cuticle of
DRhoGEF2
l(2)04291 larva ubiquitously expressing UAS-DRhoGEF2-RE. The
ventral open phenotype is rescued. (C) prd-Gal4, UAS-DRhoGEF2-RE
embryo at stage 10 is shown. Bnk (red) accumulates in prd-domains in the
epidermis. (C ) Same as in C showing DRhoGEF2 in green and Bnk in
red. Bars, 50  m. Anterior is to the left. Lateral views are shown, except
for A, which is a ventro-lateral view.ROLE OF DRHOGEF2 IN ACTOMYOSIN • PADASH BARMCHI ET AL. 581
the development of these embryos resembled DRhoGEF2 sin-
gle mutants. Metaphase furrow formation was variable and
failed in some areas (Fig. 6, E and E ), which led to the loss of
nuclei (Fig. 6 E) and the formation of empty pseudocells (Fig.
6 E ). During cellularization, the actin network of DRhoGEF2-
bnk double mutants deteriorated progressively. Breaks in actin
rings were observed more frequently than in the single mutants
(Fig. 6, F and F ), and toward the end of the slow phase, the ac-
tin network was severely fragmented. Only isolated rings were
found, but these did not constrict prematurely as observed in
bnk single mutants (Fig. 6, G and G ). At later stages, as deter-
mined by the increased depth at which actin is found, the actin
network was completely disintegrated. The majority of actin
did not associate with the invagination front but remained lo-
calized at the cortex. We conclude that bnk and DRhoGEF2
may act together to stabilize and organize actin filaments dur-
ing cellularization and that the premature constriction of actin
rings in bnk mutants requires DRhoGEF2 function.
DRhoGEF2 is required for pole cell 
formation
The first individual cells that form in the Drosophila embryo
are the germline precursors. After cortical migration of syncy-
tial nuclei, actin caps form dome-like protrusions called cyto-
plasmic buds around interphase nuclei. During nuclear cycle
10, cytoplasmic buds at the posterior pole grow extensively,
and constriction of an actin ring at the base of each bud results
in the formation of a set of pole cells (Swanson and Poodry,
1980; Foe and Alberts, 1983). DRhoGEF2 is detectable at the
membrane furrow between polar cytoplasmic buds and at the
base of the forming pole cells (Fig. 8 A), in an area where actin
rings are located. DRhoGEF2 colocalizes in these areas with
the contractile ring marker Pnut (Fig. 8 A; Neufeld and Rubin,
1994), and we suggest that DRhoGEF2 may play a role in pole
cell formation.
In DRhoGEF2 mutant embryos, polar cytoplasmic buds
form in a manner very similar to that of the wild type. Although
actin is more unevenly distributed, a set of pole cells forms at
the posterior pole (Fig. 9 A). The concentration of Pnut and
myosin II at the base between the forming pole cells suggests
that contractile rings have been assembled (Fig. 8, B and C;
and Video 1). In the wild type, the pole cells pinch off from the
somatic syncytium immediately after nuclear division cycle 10.
The pole cells of DRhoGEF2 mutants show severe defects in
actin and myosin II organization at this stage and fail to form
independent cortical actin structures that are separated from the
somatic nuclear layer (Fig. 9 B and Video 1). The defects are
particularly severe during the metaphase of nuclear divisions
(Fig. 9 C) and lead to the elimination of nuclei from the cortex,
which accumulate in the yolk at the posterior pole (Fig. 9 D and
Video 1). In contrast to wild-type pole cells, which sit on top of
the syncytium, the pole cells of DRhoGEF2 mutants remain
embedded in the somatic nuclear layer. Cellularization oc-
curs independent of these defects, and the inward movement
of the cellularization front obliterates the majority of pole
cells (Fig. 9, E–G). We conclude from these observations that
DRhoGEF2 function is required for actin distribution and for
reorganization of the actin cytoskeleton of the pole cells during
somatic syncytial divisions and cellularization.
Discussion
The role of DRhoGEF2 during development
Guanine nucleotide exchange factors regulate the activity of
the small GTPase Rho1, which is thought to act as a molecular
switch in a broad spectrum of morphogenetic processes that re-
quire a complex reorganization of the actin cytoskeleton. How-
ever, the manner in which different aspects of Rho1 function
are regulated by RhoGEFs is not well understood. We found
that DRhoGEF2 protein is broadly distributed in epithelia dur-
ing oogenesis (unpublished data) and embryonic development
and concentrated at the apical surface of cells, suggesting that it
may regulate Rho1 throughout morphogenesis. The defects of
DRhoGEF2 mutants are less severe than those of Rho1 mu-
tants, suggesting that DRhoGEF2 regulates specific aspects of
Rho1 function.
DRhoGEF2 has previously been shown to regulate cell
shape changes during gastrulation. A recent paper implicates
Figure 8. Localization of DRhoGEF2 during pole cell formation. (A) Wild
type. DRhoGEF2 (red) colocalizes with Pnut (green) at the base of polar
buds (arrowhead) and at contractile rings at the base of pole cells (arrow).
(B) DRhoGEF2
l(2)04291. Localization of Pnut (green) at the contractile ring is
unaffected (arrow). (C) DRhoGEF2
l(2)04291. Localization of myosin II (sqh-
GFP, green) at the contractile ring is unaffected (arrow). (B and C) Actin is
shown in red. (right) Merge of left two panels. Bars, 10  m.JCB • VOLUME 168 • NUMBER 4 • 2005 582
DRhoGEF2 in epithelial folding during imaginal disc devel-
opment, a process that depends on cell shape changes that
are similar to those driving invagination of the germ layers
(Nikolaidou and Barrett, 2004). In this paper, we show that
DRhoGEF2 regulates cytoskeletal reorganization and function
during pole cell formation and blastoderm cellularization. All
of these processes require the contraction of actomyosin rings.
We propose that DRhoGEF2 regulates Rho1 activity during
cell shape changes requiring actomyosin contractility. Our re-
sults support the hypothesis that individual RhoGEFs may reg-
ulate specific aspects of Rho1 function during development
(Van Aelst and D’Souza-Schorey, 1997).
Interestingly, DRhoGEF2 has been found to be nones-
sential during cytokinesis (Nikolaidou and Barrett, 2004;
(unpublished data), which also involves the function of con-
tractile actin rings. The function of Rho1 during cytokinesis
is regulated by the RhoGEF pebble that initiates actin ring
assembly (Prokopenko et al., 1999). In pebble mutants, cy-
tokinesis is blocked at mitotic cycle 14 and subsequent mi-
toses occur without cytokinesis, creating polyploid, multi-
nucleated cells. Although large multinucleated cells are
also observed in DRhoGEF2 mutants at the extended germ
band stage (not depicted) it is not clear whether these cells
are caused by a block in cytokinesis or are caused by ear-
lier defects during cellularization. In contrast to pebble,
DRhoGEF2 may not be required for the assembly of actin
rings, but may play a nonessential role in the separation of
daughter cells. This is reminiscent of our observations dur-
ing cellularization. Although the function of actin rings ap-
pears compromised throughout cellularization, our data sug-
gest that some contractile activity remains that leads to the
basal closure of blastoderm cells and is responsible for the
cellularized appearance of DRhoGEF2 mutants at the onset
of gastrulation.
At the retracted germ band stage, DRhoGEF2 is enriched
at the apical cortex of cells in the leading edge of the lateral
epidermis, which is consistent with the view that it may regu-
late Rho1 during dorsal closure. Rho1 function is essential for
dorsal closure, and the cuticles of zygotic Rho1 mutants show
dorsal holes (Harden et al., 1999; Magie et al., 1999). In
DRhoGEF2 mutants, we observed that the lateral epithelial
sheets closed the embryo dorsally. This does not exclude the
possibility that constriction of actin cables may contribute to
dorsal closure and that DRhoGEF2 may play a role in this pro-
cess. Overall, our data suggest that DRhoGEF2 function may
not be essential for the generation of contractile force, but
rather regulate the temporal and spatial coordination of acto-
myosin contractility.
The role of DRhoGEF2 during early 
embryogenesis
During syncytial nuclear divisions and cellularization,
DRhoGEF2 is localized specifically at the invaginating fur-
rows. In DRhoGEF2 mutants, actin is irregularly distributed
and metaphase furrow formation is less uniform than in the
wild type. The defects in furrow formation lead to mitotic de-
fects and the subsequent elimination of abnormal nuclei from
the cortex so that, at the onset of cellularization,  20% of the
nuclei have been lost. These phenotypes are reminiscent of the
defects seen in mutants of the nonreceptor tyrosine kinase
Abelson (Abl; Grevengoed et al., 2003). The abnormalities in
actin distribution observed in abl mutants are likely caused by
the mislocalization of Dia, which leads to ectopic actin poly-
merization at the apical end of cells. Changes in Dia distribu-
tion were not observed in DRhoGEF2 mutants, suggesting that
DRhoGEF2 may regulate actin distribution by a different
mechanism (see next section). Perturbations in actin distribu-
tion are observed throughout early development in DRhoGEF2
Figure 9. Role of DRhoGEF2 during pole cell formation. Actin is shown in red; and DNA is shown in blue. (A) Actin is irregularly distributed in polar
buds. (B) Cortical actin of pole cells fails to separate from the syncytium during interphase. (C) At metaphase, actin is disorganized and furrow formation
fails in the pole cell region. (D) At the onset of cellularization, actin surrounding the pole cells is disorganized and nuclei accumulate in the yolk at the posterior
pole (arrow). (E) During the slow phase, pole cells remain embedded in the somatic nuclear layer. (F) The invaginating cellularization front obliterates the
pole cells. (G) At the fast phase, most pole cells have been lost. All panels same magnification. Bar, 10  m. ROLE OF DRHOGEF2 IN ACTOMYOSIN • PADASH BARMCHI ET AL. 583
mutants. During cellularization, significant amounts of actin
fail to redistribute to the base of the furrow canal. These obser-
vations show that one of the roles of DRhoGEF2 is to regulate
furrow assembly. The defects in actin distribution also affect
the pole cells, which fail to reorganize their cortical actin cyto-
skeleton and remain embedded in the somatic nuclear layer
rather than sitting on top of it. Consequently, they are obliter-
ated during invagination of the cellularization front.
We speculate that DRhoGEF2 may have a function in the
assembly of actin cables by regulating the association of actin
with other proteins such as myosin II. The mislocalization of
actin observed in DRhoGEF2 mutants may be caused by fail-
ure of actin to associate with myosin. Interestingly, although
myosin II is present at the metaphase furrows, it plays no es-
sential role in their formation (Royou et al., 2004), and this
suggests that the function of DRhoGEF2 in furrow assembly
may be independent of actomyosin contractility.
Our phenotypic analysis suggests that DRhoGEF2 regu-
lates actomyosin contractility during cellularization. Previ-
ously, the actin-binding protein Bnk has been implicated in the
regulation of contractile forces (Schejter and Wieschaus, 1993).
In bnk mutants, actin hexagons detach from each other and
constrict prematurely. Based on this phenotype, Schejter and
Wieschaus (1993) proposed a model and suggested that, during
the slow phase, cortical actin hexagons are linked to each other
through Bnk, and that actomyosin constriction causes the net-
work to contract as a whole, thereby pulling the membrane
front inwards. Once the cellularization front has reached the
base of the nuclei and Bnk is degraded, actin hexagons detach
from each other and contract as individual rings, thereby clos-
ing the blastoderm cells basally. We propose that DRhoGEF2-
mediated activation of Rho1 may regulate the force that keeps
actin hexagons under tension. Bnk counteracts contraction dur-
ing the slow phase by linking individual actin rings to each
other. Degradation of Bnk during the fast phase releases indi-
vidual actin rings, and the DRhoGEF2-mediated contractile
force now contributes to basal closure. Therefore, DRhoGEF2
and bnk act in concert to coordinate actin ring contraction
during cellularization. In DRhoGEF2-bnk double mutants,
the actin network disintegrates progressively, suggesting that
DRhoGEF2 and bnk may play an additional role in the assem-
bly or stabilization of actomyosin filaments.
It has been proposed that actin network contraction con-
tributes to the inward movement of the furrow canal. Although
our data suggest that network tension is severely reduced in
DRhoGEF2 mutants, we find that the rate of membrane invagi-
nation is unaffected. This is consistent with reports on the role
of myosin II during cellularization, suggesting that network
tension may not contribute to membrane invagination (Royou
et al., 2004). In the wild type, actin rings squeeze the nuclei
slightly and push them basal-wards as the actin network moves
over them. This may contribute to the parallel alignment of as-
tral microtubules surrounding the nuclei and to nuclear elonga-
tion (Bate and Martinez Arias, 1993). In DRhoGEF2 mutants,
nuclei are wider than in the wild type and irregularly aligned.
We propose that network tension may create an ordered hexag-
onal array of actin rings that contributes to a parallel alignment
of nuclei during cellularization. The force moving the actin net-
work inward may be created by plus end–directed tracking of
actin on astral microtubules and by membrane insertion as pre-
viously suggested (Bate and Martinez Arias, 1993). Our ob-
servations suggest that actomyosin contractility plays a role
in the spatial coordination of cytoskeletal function during
cellularization.
The molecular pathway transducing 
DRhoGEF2 activity during blastoderm 
cellularization
Two effector pathways have been implicated in the transduc-
tion of Rho1 activation to the actin cytoskeleton. During cyto-
kinesis, which is mechanistically related to cellularization, a lin-
ear pathway including profilin and Dia have been proposed to
link Rho1 to the contractile actomyosin ring (Prokopenko et al.,
1999). The maternally supplied Dia plays a role in a spectrum
of cytoskeletal functions during early embryogenesis that also
require DRhoGEF2 function, such as metaphase furrow forma-
tion, pole cell formation, and cellularization. Dia is localized at
the cellularization front and is necessary for the recruitment of
cytoskeletal components such as the actin-binding protein anil-
lin and the septin homologue Pnut. The phenotypes of dia mu-
tants suggest that dia is necessary for the assembly of contrac-
tile actin rings at sites of membrane invagination (Afshar et al.,
2000).
The similarities between dia and DRhoGEF2 mutants
might suggest dia as a downstream effector of DRhoGEF2.
However, the defects of dia mutants are morphologically dif-
ferent from those of DRhoGEF2 mutants. In dia mutants,
metaphase furrows do not form and contractile rings at the base
of polar cytoplasmic buds fail to assemble. During cellulariza-
tion, actin fails to condense into individual rings, and the net-
work disintegrates during the second phase of cellularization.
In DRhoGEF2 mutants actin rings form and remain largely in-
tact but fail to constrict. In addition, the temporal and spatial
localization of Dia and Pnut to the cellularization front was un-
affected in DRhoGEF2 mutants and dia was not required for
the localization of DRhoGEF2. These findings do not exclude
that DRhoGEF2 activity may in part be mediated by dia, how-
ever, they suggest that some dia-dependent aspects of Rho1
function are still active in DRhoGEF2 mutants and that another
pathway may be involved in transduction of the DRhoGEF2
signal.
A well-characterized pathway regulating actomyosin
contractility in mammalian cells (Fukata et al., 2001) and in
Caenorhabditis elegans (Wissmann et al., 1997) links Rho1 to
actin via Rho kinase (Winter et al., 2001), the regulatory sub-
unit of myosin light chain phosphatase (MBS; Mizuno et al.,
2002; Tan et al., 2003) and myosin II. Rho kinase-mediated
phosphorylation inhibits the activity of MBS and induces a
conformational change in myosin II allowing it to form fila-
ments that promote sliding of antiparallel actin filaments. Our
data are consistent with a model in which DRhoGEF2 regulates
the association of actin with myosin II, thereby stabilizing acto-
myosin cables. We propose that failure to activate the Rho ki-
nase pathway may compromise the recruitment of actin intoJCB • VOLUME 168 • NUMBER 4 • 2005 584
contractile cables. This may destabilize actin cables and lead to
the mislocalization of actin and to the defects in actomyosin
contractility observed in DRhoGEF2 mutants. The Drosophila
homologue of Rho kinase, Drok, and myosin II have recently
been identified as downstream effectors of DRhoGEF2 during
the regulation of actomyosin contractility in Schneider (S2)
cells (Rogers et al., 2004). In addition, myosin II is required for
basal closure of blastoderm cells (Royou et al., 2004) and the
myosin II heavy chain encoded by zipper (zip) interacts geneti-
cally with DRhoGEF2 (Halsell et al., 2000). These data support
the model that DRhoGEF2 may regulate actomyosin contractil-
ity through the Rho kinase pathway. Mutants in Drok and Dro-
sophila myosin light chain phosphatase have been identified,
however, their role during early embryogenesis has not been
reported. Interestingly, inhibition of Drok activity by injection
of the specific Rho kinase inhibitor Y-27632 into embryos
before cellularization disrupts the localization of myosin II
(Royou et al., 2004). Similar observations have been made in
Drok mutant cell clones in imaginal discs (Winter et al., 2001).
By contrast, DRhoGEF2 mutants reveal no significant changes
in the localization of myosin II during cellularization. It is pos-
sible that the differences in myosin II localization between
DRhoGEF2 and Drok mutants are due to different mechanisms
of action at the molecular level. In mammalian cells myosin II
phosphorylation is required for the generation of contractile
force but not for its localization (Fumoto et al., 2003). Further
investigations will be necessary to resolve how the DRhoGEF2
signal is transduced to the cytoskeleton.
The localization of DRhoGEF2 during 
cellularization
Little is known about the events that regulate the specific sub-
cellular localization and activation of DRhoGEF2. It has re-
cently been shown that DRhoGEF2 particles are transported
from the cytoplasm to the cell periphery by tracking microtu-
bule plus ends in Drosophila S2 cells (Rogers et al., 2004). We
have observed DRhoGEF2 particles during syncytial develop-
ment that may be involved in a similar process in the embryo.
We speculate that DRhoGEF2 may be delivered to specific
membrane subdomains at the cellularization front by microtu-
bules. The G-protein  -subunit encoding gene concertina (cta)
has been shown to regulate the dissociation of DRhoGEF2
from microtubules. cta has previously been implicated in the
activation of DRhoGEF2 during gastrulation (Barrett et al.,
1997), but is not required during cellularization (Parks and
Wieschaus, 1991). It has been suggested that the force mov-
ing the actin network inward may be generated by plus end-
directed crawling of actin on astral microtubules (Bate and
Martinez Arias, 1993). We speculate that DRhoGEF2 may reg-
ulate actin ring constriction during cellularization while associ-
ated with the tip of astral microtubules by recruiting Rho1 to
the site of actin rings.
DRhoGEF2 is concentrated in actin-rich regions through-
out development and the human orthologue of DRhoGEF2,
PDZ-RhoGEF, has been shown to bind to actin directly (Baner-
jee and Wedegaertner, 2004). Although the domain structure of
DRhoGEF2 and PDZ-RhoGEF is very similar, the actin-bind-
ing region of PDZ-RhoGEF is not conserved in DRhoGEF2.
Nevertheless, the localization of DRhoGEF2 is consistent with
the view that it may associate with actin, however, further ex-
periments are needed to corroborate this theory.
Materials and methods
Fly strains and genetics
Germline clones of DRhoGEF2
l(2)04291, DRhoGEF2
4.1, DRhoGEF2
3w18, dia
5,
and Rho1
L3 were generated using the autosomal FLP-DFS technique (Chou
and Perrimon, 1996). DRhoGEF2
l(2)04291 and DRhoGEF2
4.1 are considered
null alleles (Barrett et al., 1997; Häcker and Perrimon, 1998) and showed
very similar phenotypes. All data shown regarding DRhoGEF2 mutants
were obtained from the analysis of embryos derived from females carrying
DRhoGEF2
l(2)04291 germline clones crossed with heterozygous males. Pater-
nal rescue was not observed. In DRhoGEF2
l(2)04291 mutants, no DRhoGEF2
was detectable. In embryos derived from DRhoGEF2
3w18 germline clones
wild-type DRhoGEF2 levels and distribution were observed and phenotypes
were less severe, suggesting that DRhoGEF2
3w18 is a hypomorphic allele.
Rescue of DRhoGEF2
l(2)04291 mutants was performed by crossing
DRhoGEF2
l(2)04291/P{FRT(w[hs])}G13 P{ovoD1-18}2R; mat 4-Gal-VP16/
TM3, Sb females carrying germline clones to UAS-DRhoGEF2-RE males.
DRhoGEF2
l(2)04291-bnk double mutants were made by crossing
DRhoGEF2
l(2)04291; Df(3R)tll-e females carrying germline clones with
Df(3R)tll-e/TM6b, Tb, ca males. Double mutant embryos were identified
by   -Bnk antibody staining. DRhoGEF2 mutants expressing sqh-GFP
(Royou et al., 2004) were made by crossing DRhoGEF2
l(2)04291; sqh-GFP
females carrying germline clones with sqh-GFP males. The wild-type con-
trols used were sqh-GFP/TM3, Sb females crossed with sqh-GFP males.
Rho1
L3 was made by mobilizing pBac{3xP3-EYFP, p-GAL4-K10}, us-
ing P{neoFRT}40A, P{FRT(w[hs])}G13 as a target chromosome and the
pBac insertion site was determined as described previously (Häcker et al.,
2003). The Rho1
L3 insertion is in the 5  untranslated region of Rho1 at
nt160164 in GenBank scaffold AE003808.3. The bnk mutant used was
Df(3R)tll-e (Schejter and Wieschaus, 1993). Gal4 drivers used were
mat 4Gal-VP16 (gift of D. St. Johnston, University of Cambridge, Cam-
bridge, UK) and prd-Gal4 (Yoffe et al., 1995). UAS-DRhoGEF2-RE was
generated by P element–mediated germline transformation of pUAST-
DRhoGEF2-RE (performed at the EMBL Drosophila injection service).
Molecular biology
We isolated several partial cDNAs, representing different parts of
DRhoGEF2 transcripts, by screening a random primed Drosophila embry-
onic cDNA library (CLONTECH Laboratories, Inc.). pUAST-DRhoGEF2-RE
was generated by joining a partial cDNA encompassing the region from
a unique central EcoRI site to the 3 -end of DRhoGEF2 with a cDNA repre-
senting the transcript DRhoGEF2-RE (FlyBase) from the same EcoRI site to
the 5 -end and cloning of the resulting DNA fragment into the XbaI site of
pUAST (Brand and Perrimon, 1993).
Immunohistochemistry
For phalloidin stainings, embryos were dechorionated, fixed by shaking in
4 ml HEM (100 mM Hepes, 20 mM MgSO4, and 1 mM EGTA), 4% form-
aldehyde for 20 min, devitellinized by hand using a needle, washed in
PBT (PBS containing 0.1% Tween 20), incubated in rhodamine-conjugated
phalloidin (Molecular Probes) for 1 h, washed three times in PBT, and
mounted on a microscope slide. To visualize DRhoGEF2, Rho1, Dia, Pnut,
 -Heavy spectrin, or Bnk embryos were fixed as just described, devitellin-
ized by adding 10 ml methanol and stained using rabbit  -DRhoGEF2
(Rogers et al., 2004), mouse  -Rho1 (Magie et al., 2002), mouse  -Pnut,
(obtained from the Developmental Studies Hybridoma Bank and devel-
oped under the auspices of the National Institute of Child Health and Hu-
man Development and maintained by the University of Iowa), rabbit  -Dia
(Afshar et al., 2000) (gift of S. Wasserman, University of California San
Diego, CA), rabbit  - -Heavy spectrin (gift of G. Thomas, Pennsylvania
State University, University Park, PA; Thomas and Kiehart, 1994) or rat
 -Bnk (Schejter and Wieschaus, 1993) (gift of E. Wieschaus, Princeton
University, Princeton, NJ) antibodies, respectively. DNA was stained using
TO-PRO (Molecular Probes). Primary antibodies were detected with Cy2-,
rhodamine RedX- or FITC-conjugated goat antisera (all obtained from Jack-
son ImmunoResearch Laboratories). Images were collected on a laser
scanning confocal microscope (model TCS SP2; Leica) and imported di-
rectly into Adobe Photoshop software or assembled into movies using NIH
image, ImageJ 1.62 software.ROLE OF DRHOGEF2 IN ACTOMYOSIN • PADASH BARMCHI ET AL. 585
Online supplemental material
Time-lapse videos supplement Fig. 3 (Videos 1 and 2) and Fig. 8 and Fig.
9 (Videos 1 and 3). Videos play at 10 frames/s. Fig. S1 shows the distri-
bution of DRhoGEF2 and myosin II during cellularization. Fig. S2 shows
the distribution of myosin II in DRhoGEF2 mutants. Fig. S3 provides an
overview of the phenotype of embryos derived from Rho1L3 germline
clones. Online supplemental material is available http://www.jcb.org/
cgi/content/full/jcb.200407124/DC1.
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